Results 11 to 20 of about 7,191 (206)

Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes. [PDF]

Int J Mol Sci, 2023
Bonente D, Bianchi L, De Salvo R, Nicoletti C, De Benedetto E, Bacci T, Bini L, Inzalaco G, Franci L, Chiariello M, Tosi GM, Bertelli E, Barone V.   +12 more
europepmc   +3 more sources

Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy

Case Reports in Ophthalmology, 2022
Our case emphasizes the approach of a single-dose of intraoperative methotrexate (MTX) – applied directly into silicone oil – to arrest the anomalous progression of proliferative vitreoretinopathy (PVR).
Adrian Babel, Eric K. Chin, David R.P. Almeida   +2 more
doaj   +1 more source

Experimental Models to Study Epithelial-Mesenchymal Transition in Proliferative Vitreoretinopathy. [PDF]

Int J Mol Sci, 2023
Datlibagi A, Zein-El-Din A, Frohly M, Willermain F, Delporte C, Motulsky E.   +5 more
europepmc   +3 more sources

Infectious necrotizing scleritis and proliferative vitreoretinopathy after scleral buckling in a patient with atopic dermatitis

American Journal of Ophthalmology Case Reports, 2021
Purpose: To report a case of necrotizing scleritis and proliferative vitreoretinopathy due to an acute infection following scleral buckling for the management of rhegmatogenous retinal detachment in a patient with untreated atopic dermatitis ...
Hajime Sakata, Yosuke Harada, Tomona Hiyama, Yoshiaki Kiuchi   +3 more
doaj   +1 more source

Proliferative Vitreoretinopathy: A Review [PDF]

International Ophthalmology Clinics, 2019
Proliferative vitreoretinopathy (PVR) is the most common cause for failure of rhegmatogenous retinal detachment repair and is characterized by the growth and contraction of cellular membranes within the vitreous cavity and on both sides of the retinal surface as well as intraretinal fibrosis.
Sana Idrees, Jayanth Sridhar, Ajay E. Kuriyan   +2 more
openaire   +3 more sources

Cytokines in proliferative vitreoretinopathy [PDF]

Eye, 1991
This study determined the presence of interleukin 1 (IL-1), interleukin 6 (IL-6), tumour necrosis factor alpha (TNF alpha), tumour necrosis factor beta (TNF beta), interferon gamma (IFN gamma), transforming growth factor beta 2 (TGF beta 2) and fibroblast proliferation activity (FPA) in vitreous aspirates from eyes undergoing vitrectomy for the ...
R A Wolstencroft, J A Ogilvie, Dudley C. Dumonde, Ga Limb, B C Little, W. A. Franks, Anthony H. Chignell, A Meager   +7 more
openaire   +3 more sources

Effect of etanercept on post-traumatic proliferative vitreoretinopathy [PDF]

International Journal of Ophthalmology, 2019
AIM: To evaluate the safety and efficacy of intravitreal etanercept in the inhibiting of proliferative vitreoretinopathy (PVR) in a model of penetrating ocular injury.
Xiao-Feng Chen, Mei Du, Xiao-Hong Wang, Hua Yan   +3 more
doaj   +1 more source

Outcomes and complications of primary rhegmatogenous retinal detachment repair with pars plana vitrectomy in young adults

International Journal of Retina and Vitreous, 2023
Background Scleral buckling has been the standard for rhegmatogenous retinal detachment repair in young patients given the typical lack of posterior vitreous detachment, phakic status, and lower risk of proliferative vitreoretinopathy. In older patients,
Venkatkrish M. Kasetty, Jennifer Aye, Nish Patel, Nitika Tripathi, Thomas Hessburg, Nitin Kumar, Uday R. Desai, Abdualrahman E. Hamad   +7 more
doaj   +1 more source

Comparison study of results of vitrectomy and vitrectomy with scleral buckling for the treatment of patients with rhegmatogenous retinal detachment at high risk proliferative vitreoretinopathy

Journal of Ophthalmology, 2017
he aim of our study was to analyze the effectiveness of vitrectomy and vitrectomy with scleral buckling in patients with a high risk of proliferative vitreoretinopathy.
L.A. Akhundova, M.I. Kerimov
doaj   +1 more source

Safety and Efficacy of Hypersonic Vitrectomy for Retinal Reattachment Surgery in Proliferative Vitreoretinopathies

Clinical Ophthalmology, 2022
Svenja Deuchler,1– 3 Julia Scholtz,1 Timo Knoch,4 Berthold Seitz,2 Frank H Koch1,3 1Study Centre, Augenzentrum Frankfurt, Frankfurt am Main, Hessen, Germany; 2Department of Ophthalmology, Saarland University Medical Center, Homburg, Saarland ...
Deuchler S, Scholtz J, Knoch T, Seitz B, Koch FH   +4 more
doaj